data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
ARCA biopharma
(NASDAQ:ABIO)
$2.48
-0.01[-0.40%]
At close: Jul 1
$2.48
00
After Hours: 6:53PM EDT
Day High/Low2.4 - 2.49
52 Week High/Low1.71 - 3.84
Open / Close2.45 / 2.48
Float / Outstanding14.3M / 14.4M
Vol / Avg.43.7K / 104.5K
Mkt Cap35.7M
P/E-
50d Avg. Price2.36
Div / Yield-
Payout Ratio-
EPS-0.23
Total Float14.3M

ARCA biopharma (NASDAQ:ABIO), Quotes and News Summary

ARCA biopharma (NASDAQ: ABIO)

Day High/Low2.4 - 2.49
52 Week High/Low1.71 - 3.84
Open / Close2.45 / 2.48
Float / Outstanding14.3M / 14.4M
Vol / Avg.43.7K / 104.5K
Mkt Cap35.7M
P/E-
50d Avg. Price2.36
Div / Yield-
Payout Ratio-
EPS-0.23
Total Float14.3M
Benzinga - May 2, 2022, 4:44PM
Benzinga - Apr 20, 2022, 1:04PM
Benzinga - Apr 18, 2022, 4:31PM
Benzinga - Apr 8, 2022, 5:20AM
Benzinga - Apr 5, 2022, 6:14AM
Benzinga - Apr 1, 2022, 8:20AM
Benzinga - Apr 1, 2022, 7:09AM
Benzinga - Mar 31, 2022, 4:16PM
Benzinga - Mar 14, 2022, 4:26PM
Benzinga - Dec 3, 2021, 2:20PM
Benzinga - Dec 2, 2021, 12:07PM
Benzinga - Dec 2, 2021, 8:34AM
Benzinga - Dec 2, 2021, 8:34AM
Benzinga - Nov 2, 2021, 4:46PM
Benzinga - Oct 29, 2021, 6:26AM
Benzinga - Oct 29, 2021, 5:13AM
Benzinga - Oct 28, 2021, 5:18PM
Benzinga - Sep 16, 2021, 8:36AM
load more
Sector: Health Care.Industry: Biotechnology
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.230
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ARCA biopharma Questions & Answers

Q
How do I buy ARCA biopharma (ABIO) stock?
A

You can purchase shares of ARCA biopharma (NASDAQ: ABIO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ARCA biopharma's (ABIO) competitors?
Q
What is the target price for ARCA biopharma (ABIO) stock?
A

The latest price target for ARCA biopharma (NASDAQ: ABIO) was reported by Dawson James on Wednesday, October 9, 2013. The analyst firm set a price target for 3.75 expecting ABIO to rise to within 12 months (a possible 51.21% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ARCA biopharma (ABIO)?
A

The stock price for ARCA biopharma (NASDAQ: ABIO) is $2.48 last updated July 1, 2022, 8:00 PM UTC.

Q
Does ARCA biopharma (ABIO) pay a dividend?
A

There are no upcoming dividends for ARCA biopharma.

Q
When is ARCA biopharma (NASDAQ:ABIO) reporting earnings?
A

ARCA biopharma’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is ARCA biopharma (ABIO) going to split?
A

There is no upcoming split for ARCA biopharma.

Q
What sector and industry does ARCA biopharma (ABIO) operate in?
A

ARCA biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.